Personal information

Websites & social links

https://www.dpag.ox.ac.uk

Keywords

DMD, Duchenne, Dystrophin

Countries

United Kingdom

Activities

Collapse all

Employment (18)

University of Oxford: Oxford, Oxfordshire, GB

2013 to present | Founder Member (with Profs M Wood and K Talbot) (Oxford Centre for Translational Neuromuscular Science)
Employment
Source: Self-asserted source
Kay Davies

University of Oxford: Oxford, Oxfordshire, GB

2021-10-01 to 2034-10-01 | Dr Lee's Professor of Anatomy Emeritus (Physiology, Anatomy and Genetics)
Employment
Source: Self-asserted source
Kay Davies

University of Oxford: Oxford, Oxfordshire, GB

2011-10-01 to 2021-09-30 | Associate Head (Development, Impact and Equality) (Medical Sciences Division)
Employment
Source: Self-asserted source
Kay Davies

University of Oxford Hertford College: Oxford, Oxfordshire, GB

1998-10-01 to 2021-09-30 | Fellow
Employment
Source: Self-asserted source
Kay Davies

University of Oxford: Oxford, Oxfordshire, GB

1998 to 2017-09-30 | Dr Lee's Professor of Anatomy (Physiology, Anatomy and Genetics)
Employment
Source: Self-asserted source
Kay Davies

MRC Functional Genetics Unit: Oxford, Oxfordshire, GB

1999 to 2017-03-31 | Director (honorary) (Physiology, Anatomy and Genetics)
Employment
Source: Self-asserted source
Kay Davies

University of Oxford: Oxford, Oxfordshire, GB

2008 to 2011 | Head of Department (Physiology, Anatomy and Genetics)
Employment
Source: Self-asserted source
Kay Davies

University of Oxford: Oxford, Oxfordshire, GB

2005 to 2008 | Associate Head (Physiology, Anatomy and Genetics)
Employment
Source: Self-asserted source
Kay Davies

University of Oxford: Oxford, Oxfordshire, GB

1998 to 2005 | Dr Lee's Professor of Anatomy, Head of Dept (Human Anatomy and Genetics)
Employment
Source: Self-asserted source
Kay Davies

University of Oxford: Oxford, Oxfordshire, GB

1995 to 1998 | Professor of Genetics, Genetics Unit (Biochemistry)
Employment
Source: Self-asserted source
Kay Davies

Weatherall Institute of Molecular Medicine: Oxford, Oxfordshire, GB

1995 to 1995 | MRC External Staff and Head of Molecular Genetics Group (Molecular Genetics Group)
Employment
Source: Self-asserted source
Kay Davies

Weatherall Institute of Molecular Medicine: Oxford, Oxfordshire, GB

1989 to 1992 | MRC External Staff (Molecular Genetics Group)
Employment
Source: Self-asserted source
Kay Davies

Nuffield Department of Clinical Medicine: Oxford, Oxfordshire, GB

1986 to 1989 | MRC External Staff
Employment
Source: Self-asserted source
Kay Davies

Nuffield Department of Clinical Medicine: Oxford, Oxfordshire, GB

1984 to 1986 | MRC Senior Research Fellow
Employment
Source: Self-asserted source
Kay Davies

Saint Mary's Hospital: London, London, GB

1982 to 1984 | MRC Senior Research Fellow (Biochemistry)
Employment
Source: Self-asserted source
Kay Davies

Saint Mary's Hospital: London, London, GB

1980 to 1982 | Cystic Fibrosis Research Fellow (Biochemistry)
Employment
Source: Self-asserted source
Kay Davies

Centre d'Etudes de l'Emploi: Nucleaires de Saclay, Gif-sur-Yvette, FR

1978 to 1980 | Royal Society European Post-doctorial Fellow (Biochemitry)
Employment
Source: Self-asserted source
Kay Davies

Wolfson College, University of Oxford: Oxford, Oxon, GB

1976 to 1978 | Guy Newton Junior Research Fellow
Employment
Source: Self-asserted source
Kay Davies

Education and qualifications (3)

Wolfson College, University of Oxford: Oxford, GB

1976 | D.Phil. Biochemistry
Education
Source: Self-asserted source
Kay Davies

University of Oxford: Oxford, Oxfordshire, GB

1976 | M.A.
Education
Source: Self-asserted source
Kay Davies

University of Oxford Somerville College: Oxford, Oxfordshire, GB

1973 | B.A. Chemistry
Education
Source: Self-asserted source
Kay Davies

Funding (5)

Investigating novel protective mechanisms in motor neurons

2014-10-01 to 2017-09-30 | Grant
Motor Neurone Disease Association (Northampton, GB)
URL: https://grants.uberresearch.com/501100000406/MNDA-Davies/Oct13/869-792/Investigating-novel-protective-mechanisms-in-motor-neurons
GRANT_NUMBER:

MNDA-Davies/Oct13/869-792
Source: Self-asserted source
Kay Davies via DimensionsWizard
grade
Preferred source (of 2)‎

Development of utrophin modulators for DMD

Grant
Summit Plc (Oxon, GB)
Source: Self-asserted source
Kay Davies

Small molecule upregulation of utrophin for the treatment of DMD

Grant
Muscular Dystrophy Association (AZ, AZ, US)
Source: Self-asserted source
Kay Davies

The role of utrophin in DMD and its therapeutic potential

Grant
National Medical Research Council (London, GB)
Source: Self-asserted source
Kay Davies

Utrophin modulation for the therapy of Duchenne muscular dystrophy (DMD)

Grant
Muscular Dystrophy UK (London, GB)
Source: Self-asserted source
Kay Davies

Works (9)

Personal journeys to and in human genetics and dysmorphology

American Journal of Medical Genetics Part A
2024-06 | Journal article
DOI: 10.1002/ajmg.a.63514
Contributors: Charles E. Schwartz; Arthur S. Aylsworth; Judith Allanson; Agatino Battaglia; John C. Carey; Cynthia J. Curry; Kay E. Davies; Evan E. Eichler; John M. Graham, Jr; Bryan Hall et al.
Source: check_circle
Crossref

Long-term clinical follow-up of a family with Becker muscular dystrophy associated with a large deletion in the DMD gene

Neuromuscular Disorders
2024-04 | Journal article
DOI: 10.1016/j.nmd.2024.04.004
Contributors: Kay E Davies; Julie Vogt
Source: check_circle
Crossref

Therapeutic approaches for Duchenne muscular dystrophy

Nature Reviews Drug Discovery
2023-11 | Journal article
DOI: 10.1038/s41573-023-00775-6
Contributors: Thomas C. Roberts; Matthew J. A. Wood; Kay E. Davies
Source: check_circle
Crossref

Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy

European Journal of Human Genetics
2021-09-09 | Journal article
DOI: 10.1038/s41431-021-00811-2
Contributors: Vratko Himič; Kay E. Davies
Source: check_circle
Crossref

From diagnosis to therapy in Duchenne muscular dystrophy

Biochemical Society Transactions
2020-06-30 | Journal article
DOI: 10.1042/BST20190282
Contributors: Arran Babbs; Maria Chatzopoulou; Ben Edwards; Sarah E. Squire; Isabel V.L. Wilkinson; Graham M. Wynne; Angela J. Russell; Kay E. Davies
Source: check_circle
Crossref

Publisher Correction: Therapies for rare diseases: therapeutic modalities, progress and challenges ahead

Nature Reviews Drug Discovery
2020-04-08 | Journal article
DOI: 10.1038/s41573-019-0059-7
Contributors: Erik Tambuyzer; Benjamin Vandendriessche; Christopher P. Austin; Philip J. Brooks; Kristina Larsson; Katherine I. Miller Needleman; James Valentine; Kay Davies; Stephen C. Groft; Robert Preti et al.
Source: check_circle
Crossref

Therapies for rare diseases: therapeutic modalities, progress and challenges ahead

Nature Reviews Drug Discovery
2020-02-15 | Journal article
DOI: 10.1038/s41573-019-0049-9
Contributors: Erik Tambuyzer; Benjamin Vandendriessche; Christopher P. Austin; Philip J. Brooks; Kristina Larsson; Katherine I. Miller Needleman; James Valentine; Kay Davies; Stephen C. Groft; Robert Preti et al.
Source: check_circle
Crossref

2-Arylbenzo[]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy.

Journal of medicinal chemistry
2020-01 | Journal article
DOI: 10.1021/acs.jmedchem.0c00807
PMID: 32551645
Source: check_circle
Researchfish

Surrogate gene therapy for muscular dystrophy

Nature Medicine
2019-10 | Journal article
DOI: 10.1038/s41591-019-0604-2
Contributors: Kay E. Davies; Jeffrey S. Chamberlain
Source: check_circle
Crossref

Peer review (7 reviews for 5 publications/grants)

Review activity for BioDrugs. (1)
Review activity for Communications biology. (1)
Review activity for Nature (1)
Review activity for Nature communications (2)
Review activity for Neuromuscular disorders. (2)
How many people are using ORCID?